CD8A and neoplasm: A recent study has demonstrated that pemetrexed chemotherapy can induce death of tumor cells, accelerate activation of CD8 T cells and induce upregulation of target antigens, thus altering the tumor microenvironment and increasing the efficacy of immunotherapy (25).